桃红四物汤通过调节ATF4减轻高血压患者高盐诱导的血管内皮细胞钙超载和铁下垂。

IF 4 2区 农林科学 Q2 NUTRITION & DIETETICS
Frontiers in Nutrition Pub Date : 2025-09-11 eCollection Date: 2025-01-01 DOI:10.3389/fnut.2025.1647017
Lai Kwan Lam, Peng-Li Xu, Peng-Cheng Xie, Qiu-Er Liang, Ting Xie, Lee Yam Poon, Ya Xiao, Li-Guo Chen
{"title":"桃红四物汤通过调节ATF4减轻高血压患者高盐诱导的血管内皮细胞钙超载和铁下垂。","authors":"Lai Kwan Lam, Peng-Li Xu, Peng-Cheng Xie, Qiu-Er Liang, Ting Xie, Lee Yam Poon, Ya Xiao, Li-Guo Chen","doi":"10.3389/fnut.2025.1647017","DOIUrl":null,"url":null,"abstract":"<p><strong>Background: </strong>Taohong Siwu Decoction (THSWD), a traditional Chinese medicine formula, is increasingly applied in clinical practice for hypertension management. Our previous research demonstrated that THSWD alleviates high-salt-induced hypertension in mice. This study aims to further elucidate the underlying mechanisms of THSWD in treating hypertension.</p><p><strong>Methods: </strong>The chemical composition of THSWD was identified using UPLC-Q/TOF-MS in earlier research. In this study, we performed both <i>in vivo</i> and <i>in vitro</i> experiments. <i>ATF4<sup>+/-</sup></i> mice (KO) and C57BL/6 mice (WT) were fed a high-salt diet with or without THSWD treatment. Human aortic endothelial cells (HAECs) were cultured in high-NaCl conditions, with or without ATF4 inhibition. Blood pressure, vascular injury, calcium overload, and ferroptosis were measured to evaluate the protective effects of THSWD.</p><p><strong>Results: </strong><i>In vivo</i>, a high-salt diet caused hypertension, vascular wall thickening, vascular injury, calcium overload, and ferroptosis, all of which were significantly alleviated by THSWD and the calcium-channel blocker nifedipine (NI). THSWD also reduced the high-salt-induced overexpression of ATF4. Similar effects were observed <i>in vitro</i>, where THSWD, the ferroptosis inhibitor ferrostatin-1 (Fer-1), the intracellular calcium chelator BAPTA-AM, and NI improved calcium overload and ferroptosis caused by high-NaCl. This was accompanied by reduced expression of CaMK4, CACNA1C, IP3R, RyR2, GPX4, ACSL4, and LPCAT3. Furthermore, compared to <i>ATF4<sup>+/-</sup></i> mice on a high-salt diet, those treated with THSWD showed greater reductions in blood pressure, improved vascular endothelial function, and better suppression of calcium overload and ferroptosis. Inhibition of ATF4 or co-treatment with siATF4 and THSWD <i>in vitro</i> also restored abnormal biomarker levels (iron, calcium, 12-HETE, 15-HETE, GSH, GSH/GSSG, MDA, and LPO) and normalized calcium overload- and ferroptosis-related markers.</p><p><strong>Conclusion: </strong>THSWD effectively lowers blood pressure and protects against vascular damage in high-salt-induced hypertension. Its protective effects are achieved by inhibiting calcium overload and ferroptosis through the regulation of ATF4.</p>","PeriodicalId":12473,"journal":{"name":"Frontiers in Nutrition","volume":"12 ","pages":"1647017"},"PeriodicalIF":4.0000,"publicationDate":"2025-09-11","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC12461095/pdf/","citationCount":"0","resultStr":"{\"title\":\"Taohong Siwu Decoction alleviates high salt-induced calcium overload and ferroptosis in vascular endothelial cells in hypertension by regulating ATF4.\",\"authors\":\"Lai Kwan Lam, Peng-Li Xu, Peng-Cheng Xie, Qiu-Er Liang, Ting Xie, Lee Yam Poon, Ya Xiao, Li-Guo Chen\",\"doi\":\"10.3389/fnut.2025.1647017\",\"DOIUrl\":null,\"url\":null,\"abstract\":\"<p><strong>Background: </strong>Taohong Siwu Decoction (THSWD), a traditional Chinese medicine formula, is increasingly applied in clinical practice for hypertension management. Our previous research demonstrated that THSWD alleviates high-salt-induced hypertension in mice. This study aims to further elucidate the underlying mechanisms of THSWD in treating hypertension.</p><p><strong>Methods: </strong>The chemical composition of THSWD was identified using UPLC-Q/TOF-MS in earlier research. In this study, we performed both <i>in vivo</i> and <i>in vitro</i> experiments. <i>ATF4<sup>+/-</sup></i> mice (KO) and C57BL/6 mice (WT) were fed a high-salt diet with or without THSWD treatment. Human aortic endothelial cells (HAECs) were cultured in high-NaCl conditions, with or without ATF4 inhibition. Blood pressure, vascular injury, calcium overload, and ferroptosis were measured to evaluate the protective effects of THSWD.</p><p><strong>Results: </strong><i>In vivo</i>, a high-salt diet caused hypertension, vascular wall thickening, vascular injury, calcium overload, and ferroptosis, all of which were significantly alleviated by THSWD and the calcium-channel blocker nifedipine (NI). THSWD also reduced the high-salt-induced overexpression of ATF4. Similar effects were observed <i>in vitro</i>, where THSWD, the ferroptosis inhibitor ferrostatin-1 (Fer-1), the intracellular calcium chelator BAPTA-AM, and NI improved calcium overload and ferroptosis caused by high-NaCl. This was accompanied by reduced expression of CaMK4, CACNA1C, IP3R, RyR2, GPX4, ACSL4, and LPCAT3. Furthermore, compared to <i>ATF4<sup>+/-</sup></i> mice on a high-salt diet, those treated with THSWD showed greater reductions in blood pressure, improved vascular endothelial function, and better suppression of calcium overload and ferroptosis. Inhibition of ATF4 or co-treatment with siATF4 and THSWD <i>in vitro</i> also restored abnormal biomarker levels (iron, calcium, 12-HETE, 15-HETE, GSH, GSH/GSSG, MDA, and LPO) and normalized calcium overload- and ferroptosis-related markers.</p><p><strong>Conclusion: </strong>THSWD effectively lowers blood pressure and protects against vascular damage in high-salt-induced hypertension. Its protective effects are achieved by inhibiting calcium overload and ferroptosis through the regulation of ATF4.</p>\",\"PeriodicalId\":12473,\"journal\":{\"name\":\"Frontiers in Nutrition\",\"volume\":\"12 \",\"pages\":\"1647017\"},\"PeriodicalIF\":4.0000,\"publicationDate\":\"2025-09-11\",\"publicationTypes\":\"Journal Article\",\"fieldsOfStudy\":null,\"isOpenAccess\":false,\"openAccessPdf\":\"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC12461095/pdf/\",\"citationCount\":\"0\",\"resultStr\":null,\"platform\":\"Semanticscholar\",\"paperid\":null,\"PeriodicalName\":\"Frontiers in Nutrition\",\"FirstCategoryId\":\"97\",\"ListUrlMain\":\"https://doi.org/10.3389/fnut.2025.1647017\",\"RegionNum\":2,\"RegionCategory\":\"农林科学\",\"ArticlePicture\":[],\"TitleCN\":null,\"AbstractTextCN\":null,\"PMCID\":null,\"EPubDate\":\"2025/1/1 0:00:00\",\"PubModel\":\"eCollection\",\"JCR\":\"Q2\",\"JCRName\":\"NUTRITION & DIETETICS\",\"Score\":null,\"Total\":0}","platform":"Semanticscholar","paperid":null,"PeriodicalName":"Frontiers in Nutrition","FirstCategoryId":"97","ListUrlMain":"https://doi.org/10.3389/fnut.2025.1647017","RegionNum":2,"RegionCategory":"农林科学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"2025/1/1 0:00:00","PubModel":"eCollection","JCR":"Q2","JCRName":"NUTRITION & DIETETICS","Score":null,"Total":0}
引用次数: 0

摘要

背景:桃红四物汤(THSWD)是一种中药方剂,在临床上越来越多地应用于高血压治疗。我们之前的研究表明,THSWD可以缓解高盐诱导的小鼠高血压。本研究旨在进一步阐明THSWD治疗高血压的潜在机制。方法:在前期研究中,采用UPLC-Q/TOF-MS对三氯乙酸乙酯的化学成分进行鉴定。在这项研究中,我们进行了体内和体外实验。ATF4+/-小鼠(KO)和C57BL/6小鼠(WT)分别饲喂高盐饲粮和不加THSWD治疗。人主动脉内皮细胞(HAECs)在高nacl条件下培养,有或没有ATF4抑制。通过测量血压、血管损伤、钙超载和铁下垂来评估THSWD的保护作用。结果:在体内,高盐饮食引起高血压、血管壁增厚、血管损伤、钙超载和铁下垂,THSWD和钙通道阻滞剂硝苯地平(NI)均可显著缓解这些症状。THSWD还能降低高盐诱导的ATF4过表达。在体外也观察到类似的效果,THSWD、铁下垂抑制剂铁抑素-1 (fer1)、细胞内钙螯合剂BAPTA-AM和NI改善了高nacl引起的钙超载和铁下垂。同时伴有CaMK4、CACNA1C、IP3R、RyR2、GPX4、ACSL4和LPCAT3的表达降低。此外,与高盐饮食的ATF4+/-小鼠相比,接受THSWD治疗的小鼠表现出更大的血压降低,血管内皮功能改善,更好地抑制钙超载和铁下垂。体外抑制ATF4或与siATF4和THSWD共同处理也能恢复异常的生物标志物水平(铁、钙、12-HETE、15-HETE、GSH、GSH/GSSG、MDA和LPO),并使钙超载和铁中毒相关标志物正常化。结论:高盐高血压患者可有效降低血压,预防血管损伤。其保护作用是通过调节ATF4抑制钙超载和铁下垂来实现的。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
Taohong Siwu Decoction alleviates high salt-induced calcium overload and ferroptosis in vascular endothelial cells in hypertension by regulating ATF4.

Background: Taohong Siwu Decoction (THSWD), a traditional Chinese medicine formula, is increasingly applied in clinical practice for hypertension management. Our previous research demonstrated that THSWD alleviates high-salt-induced hypertension in mice. This study aims to further elucidate the underlying mechanisms of THSWD in treating hypertension.

Methods: The chemical composition of THSWD was identified using UPLC-Q/TOF-MS in earlier research. In this study, we performed both in vivo and in vitro experiments. ATF4+/- mice (KO) and C57BL/6 mice (WT) were fed a high-salt diet with or without THSWD treatment. Human aortic endothelial cells (HAECs) were cultured in high-NaCl conditions, with or without ATF4 inhibition. Blood pressure, vascular injury, calcium overload, and ferroptosis were measured to evaluate the protective effects of THSWD.

Results: In vivo, a high-salt diet caused hypertension, vascular wall thickening, vascular injury, calcium overload, and ferroptosis, all of which were significantly alleviated by THSWD and the calcium-channel blocker nifedipine (NI). THSWD also reduced the high-salt-induced overexpression of ATF4. Similar effects were observed in vitro, where THSWD, the ferroptosis inhibitor ferrostatin-1 (Fer-1), the intracellular calcium chelator BAPTA-AM, and NI improved calcium overload and ferroptosis caused by high-NaCl. This was accompanied by reduced expression of CaMK4, CACNA1C, IP3R, RyR2, GPX4, ACSL4, and LPCAT3. Furthermore, compared to ATF4+/- mice on a high-salt diet, those treated with THSWD showed greater reductions in blood pressure, improved vascular endothelial function, and better suppression of calcium overload and ferroptosis. Inhibition of ATF4 or co-treatment with siATF4 and THSWD in vitro also restored abnormal biomarker levels (iron, calcium, 12-HETE, 15-HETE, GSH, GSH/GSSG, MDA, and LPO) and normalized calcium overload- and ferroptosis-related markers.

Conclusion: THSWD effectively lowers blood pressure and protects against vascular damage in high-salt-induced hypertension. Its protective effects are achieved by inhibiting calcium overload and ferroptosis through the regulation of ATF4.

求助全文
通过发布文献求助,成功后即可免费获取论文全文。 去求助
来源期刊
Frontiers in Nutrition
Frontiers in Nutrition Agricultural and Biological Sciences-Food Science
CiteScore
5.20
自引率
8.00%
发文量
2891
审稿时长
12 weeks
期刊介绍: No subject pertains more to human life than nutrition. The aim of Frontiers in Nutrition is to integrate major scientific disciplines in this vast field in order to address the most relevant and pertinent questions and developments. Our ambition is to create an integrated podium based on original research, clinical trials, and contemporary reviews to build a reputable knowledge forum in the domains of human health, dietary behaviors, agronomy & 21st century food science. Through the recognized open-access Frontiers platform we welcome manuscripts to our dedicated sections relating to different areas in the field of nutrition with a focus on human health. Specialty sections in Frontiers in Nutrition include, for example, Clinical Nutrition, Nutrition & Sustainable Diets, Nutrition and Food Science Technology, Nutrition Methodology, Sport & Exercise Nutrition, Food Chemistry, and Nutritional Immunology. Based on the publication of rigorous scientific research, we thrive to achieve a visible impact on the global nutrition agenda addressing the grand challenges of our time, including obesity, malnutrition, hunger, food waste, sustainability and consumer health.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
确定
请完成安全验证×
copy
已复制链接
快去分享给好友吧!
我知道了
右上角分享
点击右上角分享
0
联系我们:info@booksci.cn Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号:604180095
Book学术官方微信